The gene (crc) responsible for catabolite repression control in Pseudomonas aeruginosa has been cloned and sequenced. Flanking the crc gene are genes encoding orotate phosphoribosyl transferase (pyrE) and RNase PH (rph). New crc mutants were constructed by disruption of the wild-type crc gene. The crc gene encodes an open reading frame of 259 amino acids with homology to the apurinic/apyrimidinic endonuclease family of DNA repair enzymes. However, crc mutants do not have a DNA repair phenotype, nor can the crc gene complement Escherichia coli DNA repair-deficient strains. The crc gene product was overexpressed in both P. aeruginosa and in E. coli, and the Crc protein was purified from both. The purified Crc proteins show neither apurinic/ apyrimidinic endonuclease nor exonuclease activity. Antibody to the purified Crc protein reacted with proteins of similar size in crude extracts from Pseudomonas putida and Pseudomonas fluorescens, suggesting a common mechanism of catabolite repression in these three species.
The genus Pseudomonas is noteworthy for its diversity in habitat and physiology. Some Pseudomonas strains are able to use over 100 organic compounds as the sole or principal source of carbon. Pseudomonas aeruginosa can utilize at least 80 different organic compounds (41) . A mechanism of catabolite repression control exists in these organisms (18) which prevents them from wasting energy maintaining the enzymes for all these catabolic pathways and ensures the preferential utilization of the most efficient source of carbon and energy. Such a regulatory mechanism has also been identified in the enteric bacteria (20) and in Bacillus spp. (6) .
In the enteric bacteria, the molecular mechanism of catabolite repression control involves a catabolite activator protein (Cap) which, when bound to cyclic AMP (cAMP), interacts with promoter regions of regulated genes to facilitate the binding of RNA polymerase, thereby initiating transcription (20) . In the presence of glucose, the cAMP pool is lowered, Cap is not bound, and the regulated genes are not transcribed (i.e., they are repressed). The effect of glucose on cAMP pools is mediated by components of the phosphoenolpyruvate phosphotransferase system which also serve to activate adenylate cyclase (33) . Since the initial identification of these regulatory components, catabolite repression has proven to be a global mechanism in the enteric bacteria, affecting at least 28 separate promoters which regulate biosynthetic as well as catabolic operons (7) . It also has been found to act as a negative regulator as well as a positive regulator (1, 7, 23, 24) .
In Bacillus spp. catabolite repression is not mediated by glucose, nor is cAMP involved (6, 37, 40) . Genetic evidence has implicated the catabolite control protein (CcpA), a member of the GalR family of repressor proteins (6) , Hpr, a component of the phosphoenolpyruvate phosphotransferase system (9) , and a cis-acting DNA sequence (CRE) (15, 48) . Recent work has shown that HPr specifically phosphorylated at Ser-46 forms a complex with CcpA capable of protecting the CRE from DNase digestion (11) , suggesting a global regulatory model for catabolite repression in Bacillus spp. (11, 14) .
In P. aeruginosa and Pseudomonas putida, acetate and intermediates of the tricarboxylic acid cycle are the strongest repressing substrates, although glucose can cause repression of some catabolic pathways, such as that of mannitol utilization (38) . Further, neither cAMP nor adenylate cyclase appears to play a role in catabolite repression control (29, 38) . To date, the molecular mechanism of catabolite repression control in these organisms is completely unknown. Recently we described the isolation of the first mutants in catabolite repression control (crc) in P. aeruginosa (47) . Their phenotype is the failure to repress multiple independently regulated pathways when grown in the presence of tricarboxylic acid cycle intermediates (47) . We subsequently cloned a gene which restores wild-type regulation to these mutants (19) . Here we report the nucleotide sequences for the crc region, the comparison of the derived protein sequences to other known proteins, and the significance of this comparison to the function of the Crc protein.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Bacterial strains and plasmids used in this study are listed in Table 1 . P. aeruginosa was grown at 37ЊC in basal salts medium (BSM) (16) or in Luria-Bertani (LB) medium (22) . Pseudomonas fluorescens and P. putida were grown at 30ЊC in LB medium. Antibiotics were used at the following concentrations: tetracycline (TET), 100 g/ml for P. aeruginosa and 20 g/ml for Escherichia coli; carbenicillin (CB), 500 g/ml for P. aeruginosa; ampicillin (AMP), 100 g/ml for E. coli.
Mutant construction and transfer of plasmids. Pseudomonas strain PAO8020, carrying the crc mutation, was constructed as follows: from the 2-kb insert of plasmid pPZ353, a 0.3-kb AccI fragment was replaced with a Tc r cassette (see Fig. 1 for diagram; pPZ353 is identical to pPZ354 except that it lacks an oriV). The truncated crc gene containing the Tc r cassette was cut from this plasmid and inserted into pUC19mob to produce pPZ407. pUC19mob carries the mob region of pRP4 (26) which acts in trans with the tra genes carried on the chromosome of E. coli S17-1 to mobilize the conjugal transfer of this plasmid into a broad range of gram-negative bacteria (39) . Donor cells (S17-1 containing pPZ407) and recipient cells (P. aeruginosa PAO1) were grown to log phase in LB medium. These cells were mixed in a 1:1 ratio, and 2 ml of this mix was filtered onto a sterile 0.45-m-pore-size filter. Filters were incubated at 37ЊC on LB plates overnight, and then removed from the plates and washed with 50 mM potassium phosphate, pH 7. Washed cells were concentrated by centrifugation and suspended in 1 ml of the same buffer, and 100 l was plated on selective medium. Plates were incubated at 37ЊC for up to 60 h. Transconjugants which were Tc r and Cb s were assumed to be double crossovers in which the chromosomal wild-type crc gene was replaced by the mutant crc gene encoding a C-terminal deletion of the Crc coding sequence. Pseudomonas strain 8023, carrying the crc mutation, was constructed as follows: an ApaI restriction site was introduced at codon 35 of the Crc coding sequence (see Fig. 1 ) by using an in vitro oligonucleotide mutagenesis kit (Amersham Corporation, Arlington Heights, Ill.). Then the 0.5-kb ApaI-PvuII fragment with 5Ј and 3Ј deletions of the crc gene was cloned into pUC19mob to create pPZ471. pPZ471 was introduced into P. aeruginosa PAO1 as described above, and Cb r transconjugants were selected and assumed to be single crossovers in which the chromosomal wild-type crc gene was replaced by tandem crc alleles, one containing a C-terminal and one containing an N-terminal deletion of the Crc coding sequence.
Transformation was employed to move plasmids into E. coli and P. aeruginosa. E. coli was made competent by the CaCl 2 procedure (21). P. aeruginosa strains were made competent by a similar procedure but with MgCl 2 substituted for CaCl 2 (19) .
Plasmid isolation, mapping, and subcloning. All procedures were essentially as described in Maniatis et al. (21) . Plasmids were propagated in E. coli DH5␣.
DNA sequencing. DNA sequencing was carried out by the dideoxy chain termination method by using Taq polymerase as described by the manufacturer (Promega Corporation, Madison, Wis.). The reaction mixtures included 7-Deaza dGTP and were run on polyacrylamide gels containing 20% dimethylformamide.
Single-stranded DNA was used as the template for sequencing reactions. It was derived from subclones in pTZ18R, produced in E. coli DH5␣FЈ with the helper phage M13K07, and prepared according to the supplier of the helper phage (Promega Corporation). Oligonucleotides prepared by the East Carolina University School of Medicine Biotechnology Program DNA Synthesis Core Laboratory were used to sequence both DNA strands. Additional DNA sequencing was done by the automated DNA sequencing facility at the University of North Carolina, Chapel Hill.
Sequence analyses. Nucleotide and protein sequence analyses were carried out using the University of Wisconsin Genetics Computer Group software package and the Basic Local Alignment Search Tool (BLAST) Network Service at the National Center for Biotechnology Information, National Institutes of Health (2) .
Enzyme assays. Measurements of [ 14 C]mannitol uptake and incorporation and glucose-6-phosphate dehydrogenase and amidase activities were described previously (19) . Glucose-6-phosphate dehydrogenase was measured by using the soluble fraction from crude cell extracts. Extract preparation is described below. Mannitol uptake and amidase activities were measured with washed whole cells. Apurinic/apyrimidinic (AP) endonuclease assays were done with partially depurinated plasmid DNA and analyzed by gel electrophoresis (3) . Purified human Ref-1 used as a control was the generous gift of Steven Xanthodakis (Roche Biomedical, Nutley, N.J.). Additional AP endonuclease assays were performed in the laboratory of Miriam Sander (NIEHS, Research Triangle Park, N.C.) by using a synthetic oligonucleotide substrate (25) . Exonuclease assays were performed on linearized plasmid DNA with E. coli ExoIII (Promega Corporation) as a positive control (3) .
Expression of the crc gene product in P. aeruginosa and E. coli. To express the crc gene product in P. aeruginosa, the 922-bp fragment (pPZ448) (see Fig. 1 ) was cloned into pEB16, placing the Crc coding sequence downstream of a T7 promoter (5). The resulting plasmid, pPZ456, was transformed into P. aeruginosa ADD1976, which contains the T7 polymerase under the control of the lac promoter on the chromosome (4). To achieve maximum expression of the crc gene product, ADD1976 containing pPZ456 was grown for several generations in LB medium and, at an optical density at 600 nm of 0.8, 2 mM isopropylthio-␤-D-galactopyranoside (IPTG) was added. After continued growth for 4 h at 37ЊC, rifampin (200 g/ml) was added, and the cells were incubated for another 4 h. The cells were harvested by centrifugation, suspended in 20 mM Tris, pH 6.8, and disrupted in a French pressure cell at 16,000 psi. The cell envelope was removed by centrifugation at 200,000 ϫ g, and the resulting supernatant was loaded onto a column containing Macro-Prep High Q anion exchange resin (Bio-Rad Laboratories, Hercules, Calif.). The column was washed with 2 column volumes of 20 mM Tris, pH 6.8; this was followed by 1 column volume of 20 mM Tris, pH 6.8, containing 100 mM NaCl. Subsequently, the Crc protein was eluted with 20 mM Tris, pH 6.8, containing 160 mM NaCl.
For expression of the crc gene product in E. coli, the crc gene was cloned into the vector pQE32 (Qiagen Inc., Chatsworth, Calif.). This vector contains a T5 promoter, two lac operators, and a ribosome binding site at the appropriate distance from an ATG codon. It also places six histidine residues at the N terminus of the gene product, allowing the specific binding of the expressed protein to a nickel-nitrilo-tri-acetic acid (Ni-NTA) resin. In order to insert the crc gene in frame with the ATG, a KpnI site was introduced 6 bp upstream of the crc initiation codon by using an oligonucleotide-directed in vitro mutagenesis system (see above). The crc gene was then excised as an 883-bp KpnI-StuI fragment which was inserted into the KpnI-SmaI site in the vector pQE32. The resulting Crc fusion protein produced from this plasmid contains an additional 20 amino acids (including the six histidines added by the vector) at the N terminus. pQE32 containing the crc gene, pPZ461, was transformed into E. coli M15 which also contained a second plasmid with the lacI q gene, permitting tight control of crc gene expression in the absence of IPTG. These cells were grown to an optical density at 600 nm of approximately 0.8 in LB medium, at which time 2 mM IPTG was added and growth was continued for an additional 4 h. The culture was harvested by centrifugation, suspended in 100 mM Tris, pH 7.4, and soluble cell extracts were prepared as above. The Crc fusion protein was purified on a Ni-NTA column used as recommended by the supplier (Qiagen).
Analysis of cell extracts by SDS-polyacrylamide gel electrophoresis. To isolate soluble protein fractions, cells were disrupted in a French pressure cell at 16,000 psi and centrifuged at 200,000 ϫ g for 30 min. The resulting supernatants were solubilized in an equal volume of sample buffer, heated to 100ЊC for 5 min, and run on sodium dodecyl sulfate (SDS) polyacrylamide gels (19) .
Protein sequencing. Sequencing was performed in the East Carolina University School of Medicine Biotechnology Program Protein Sequencing Core Laboratory on a Milligen-Biosearch Model 6625 Prosequencer (Millipore Corp., Marlborough, Mass.). For each run, 10 g of protein was coupled to a diisothiocyanate disk.
Antibody production. Crc fusion protein (500 g) was combined with 2 volumes of complete Freund's adjuvant and injected intramuscularly into a New Zealand White rabbit. The rabbit was boosted in a similar fashion with 500 g of the same protein mixed with incomplete Freund's adjuvant and, finally, boosted twice more with 50 g of the protein alone, injected subcutaneously.
Western blots (immunoblots).
Purified Crc protein or cell extracts from the various Pseudomonas or E. coli strains were run on SDS polyacrylamide gels, and proteins were transferred to Immobilon-P membranes (Millipore Corp., Bed- Fig. 4 ) containing the Crc coding sequence was assigned GenBank accession number L12038.
RESULTS
Nucleotide sequence of the crc region. In previous cloning experiments (19), we identified a 2-kb piece of P. aeruginosa chromosomal DNA that was able to restore a wild-type phenotype to crc mutants (i.e., plasmid pPZ354). This DNA codes for a protein with a molecular mass of approximately 30 kDa, assumed to be the crc gene product (19) . We sequenced 3 kb of the crc region and found three genes, crc, pyrE, and a novel P. aeruginosa gene which we have designated rph (Fig. 1) . Since the crc gene was known to be linked to pyrE (19) , it was no surprise to find the coding sequence for orotate phosphoribosyl transferase, the gene product of pyrE. On the other side of crc the DNA sequence encodes a protein with 68% identity to the RNase PH of E. coli. Given that the rph gene of E. coli (encoding RNase PH) is adjacent to pyrE, we have named this the rph gene for P. aeruginosa. Figure 2 compares the deduced amino acid sequences of orotate phosphoribosyl transferase and RNase PH with their E. coli homologs.
The nucleotide sequence of the crc gene and the predicted amino acid sequence of the Crc protein are shown in Fig. 3 . Amino acid analysis of the purified crc gene product (see below) demonstrated that protein synthesis initiates at the ATG located at position 97. All of these genes show a strong bias for G/C residues in the third base of their codons (Crc, 81%; PyrE, 86%; and Rph, 91%) consistent with other genes expressed in P. aeruginosa. A potential ribosome binding site (GGGGG) was identified 7 to 11 bp upstream of the ATG for Crc. This is an atypical ribosome binding site for P. aeruginosa and might explain the lower expression of the crc gene in E. coli (see below). A stop codon (TGA) at position 874 produced an open reading frame (ORF) of 777 bp. A protein produced from this ORF would have a molecular mass of 28.5 kDa, in close agreement with the 30-kDa protein identified on SDS polyacrylamide gels (19) . At positions 894 to 919, 18 bp after the stop codon, a strong factor-independent transcriptional terminator 26 bp in length was identified by using the TER-MINATOR program. The PEPTIDESTRUCTURE program predicts that the Crc protein is very hydrophilic, which is consistent with the identification of this gene product in the soluble fraction of P. aeruginosa (19) . 2 ). pPZ352 was constructed by subcloning a 3.1-kb PstI-EcoRV fragment from pPZ341 into pPZ343 (19) . Vector pPZ343 is pTZ18R containing a broad-host-range origin (oriV) derived from pRO1614 (28) to allow replication in Pseudomonas spp. The construction of pPZ354 was described previously (19) (plasmid pPZ353 is identical except that it lacks an oriV). pPZ441 was constructed by isolating a 1.2-kb RsaI fragment from pPZ354 and inserting this into the SmaI site of pPZ343. pPZ445 was created by deleting a 0.7-kb ApaI-SmaI fragment from pPZ354. pPZ448 was created by deleting a 1-kb StuI-SmaI fragment from pPZ354. In all plasmids, except pPZ352, the lac promoter of the vector is in the same orientation as crc. The location of the tetracycline resistance cassette used to disrupt the crc gene is indicated. ‫,ء‬ location of the engineered ApaI site subsequently used in the construction of the crc deletion strain PAO8023. 
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Genetic identification of the crc structural gene. In order to confirm our identification of the crc gene, we subcloned the crc region and tested these clones for complementation of the crc mutation. In addition we have constructed new defined mutations (knockouts) of the chromosomal copy of crc.
PAO1 (wild type) shows repression of the mannitol pathway and amidase when grown in the presence of succinate plus the appropriate inducer. However, these activities are not repressed in crc mutants (46) . When a plasmid carrying the crc gene is introduced into crc mutants, these activities become sensitive to repression by succinate and are lowered to the levels seen in the wild type (19) . Figure 1 summarizes the complementation results that are presented in Fig. 4 . The smallest plasmid able to restore a wild-type phenotype to the crc mutants was pPZ448. This plasmid contained an SstI-StuI fragment 922 bp in length. When soluble proteins from PAO8007 containing pPZ448 or the original 2-kb subclone, pPZ354, were analyzed on SDS polyacrylamide gels stained with Coomassie blue, a major band in both of these extracts had an approximate molecular mass of 30 kDa (data not shown) (19) . This band was not present in PAO8007 containing only the vector. This confirmed our previous conclusion (19) that the crc gene product has a molecular mass of approximately 30 kDa.
To create new crc mutants, the crc gene was disrupted by replacing the 0.3-kb AccI fragment from the insert in pPZ354 (see Fig. 1 ) with a tetracycline resistance cassette and inserting this defective crc gene into the chromosome of PAO1 by homologous recombination. This construction deleted the last 24 bp from the end of the gene as well as the terminator and some downstream sequence. This construct was derived from pPZ353, which is identical to pPZ354 except that it cannot replicate in Pseudomonas spp. Figure 5 shows that this deletion mutant, PAO8020, has a phenotype identical to other crc mutants which either arose spontaneously or were produced by chemical mutagenesis (46) . Southern analysis of PAO8020 showed that it contained only a single copy of the crc gene and that the Tc r cassette was located within this gene (3). The wild-type phenotype could be restored to PAO8020 by transformation with both pPZ354 and pPZ448 (Fig. 3) . Thus the DNA contained within the 922-bp SstI-StuI fragment is sufficient to complement this mutation.
We subsequently constructed a second strain, PAO8023, by recombination of a 5Ј-and 3Ј-deleted copy of the crc gene (containing the coding sequence for amino acids 36 to 201 of the Crc sequence) into PAO1. PAO8023 is also phenotypically a crc mutant (data not shown).
Homology of the crc gene product to AP endonucleases. We compared the deduced amino acid sequence of the crc gene product to that of other proteins by using the FASTA, TFASTA, and BLAST programs. The only strong candidates for related proteins belonged to a family of DNA repair enzymes found in both prokaryotes and eukaryotes. The repair FIG. 3 . Nucleotide sequence of the P. aeruginosa DNA fragment contained in pPZ352, extending from 16 bp within the pyrE coding sequence to the StuI site (976). The region underlined (894 to 919) is a strong stem-loop structure with the properties of a factor-independent terminator. The crc structural gene starts at the ATG at position 97. A potential Shine-Dalgarno sequence, GGGGG, is located at positions 86 to 90. Fig. 1 . Each plasmid was transformed into PAO8007, and all strains were grown for two generations in BSM containing 40 mM succinate plus 5 mM [
FIG. 4. Complementation of crc mutant PAO8007 with plasmids shown in
14 C]mannitol (for uptake and incorporation) or 40 mM succinate plus 20 mM lactamide (for amidase). Assays were performed as previously described (19) . Enzyme activity in PAO1 is expressed as 100% of each specific activity (1.2 mol/mg of protein for amidase and 115 nmol/mg of protein for mannitol uptake). All others are expressed as a percentage of that found in PAO1. Symbols: s, PAO1; ᮀ, PAO8007;^, PAO8007/pPZ354; u, PAO8007/pPZ448; d, PAO8007/pPZ445; s, PAO8007/pPZ441. (27) . They range in identity to Crc from 25 to 32% and in similarity to Crc from 51 to 57%. Homologies in these same ranges are found when the prokaryotic enzymes are compared with the eukaryotic enzymes or when the prokaryotic enzymes are compared with each other. Areas of identity are not located at a particular region of each protein but exist throughout all these proteins, including Crc. These homologies are illustrated in Fig. 6 . All these proteins (with the exception of B. subtilis ExoA which has yet to be isolated) possess AP endonuclease activity and are theorized to be involved in some way in DNA repair. Recently, an ORF was identified in Coxiella burnetii (44) which codes for a putative protein with a 44% identity to crc. This putative protein is also shown in Fig. 6 . In C. burnetii this ORF is adjacent to a homolog of orotate phosphoribosyl transferase. It is intriguing to note that this ORF and crc are adjacent to and divergently expressed from the orotate phosphoribosyl transferases. In P. aeruginosa there are 80 bp between the ATG start codons for pyrE and crc, while in C. burnetii there are 50 bp between ATGs.
As an initial test for a DNA repair activity in the Crc protein, we compared the sensitivities of P. aeruginosa PAO1 (crc ϩ ), PAO8007 (crc-20), and PAO8020 (⌬crc) to DNA damaging agents. E. coli xth (ExoIII) mutants are extremely sensitive to alkylating agents such as methyl methanesulfonate and mitomycin C and oxidizing agents such as H 2 O 2 (8) . At concentrations of these agents which caused a decrease in survival of PAO1 of less than 1 log, no greater sensitivity was observed in either PAO8007 or PAO8020 (data not shown).
Since there may be redundant recombination repair activities in Pseudomonas spp. that would mask the phenotype of a single mutation, we also tested the Crc protein for AP endo- Fig. 1 . Plasmids pPZ448 and pPZ354 and the vector, pPZ343, were transformed into PAO8020, and all strains were grown for two generations in BSM containing 40 mM succinate plus 5 mM [
14 C]mannitol (for uptake and incorporation), 40 mM succinate plus 20 mM mannitol (for glucose-6-phosphate dehydrogenase), or 40 mM succinate plus 20 mM lactamide (for amidase). Assays were performed as previously described (19) . Enzyme activity in PAO1 is expressed as 100% of specific activity (0.83 mol/mg of protein for amidase, 10.4 nmol/mg of protein for glucose-6-phosphate dehydrogenase, and 215 nmol/mg of protein for mannitol uptake). All others are percentages of that found in PAO1. Symbols: s, PAO1; ᮀ, PAO8007;^, PAO8020; u, PAO8020/ pPZ343;`, PAO8020/pPZ448; s, PAO8020/pPZ354. VOL. 178, 1996 NUCLEOTIDE SEQUENCE AND EXPRESSION OF THE crc GENE 5631 nuclease activity in vivo by using two E. coli mutants. E. coli strains BW287 and BW549 contain a temperature-sensitive mutation in the xth gene (ExoIII), giving them lower survival rates at increased growth temperatures (8, 44) . Both strains contain a dut-1 mutation to generate AP sites in the DNA. BW549 also contains a mutation in the nfo gene which codes for endonuclease IV, giving it an even lower survival rate than BW287 (8) . Previous studies indicated that other genes in this AP endonuclease family (ref-1 and rrp1) can replace the xth gene in these mutants and restore wild-type survival rates at elevated temperature (12, 31) . We performed a similar experiment by comparing the plating efficiency of BW287 and BW549 carrying plasmids containing the ref-1 gene, the crc gene, and the crc fusion gene (crc-f) with the plating efficiency of each of these strains carrying no plasmid or vector only. Table 2 shows that neither form of the crc gene could replace the temperature-sensitive ExoIII protein at 42ЊC, while the Ref-1 protein could. To confirm that the crc gene was actually being expressed in these E. coli strains, Western blots were performed (as described below). In both strains containing the crc or crc-f genes, a band was recognized by the anti-Crc antisera at the correct location. No band was observed in the controls (3). Expression of the purified crc gene product. We purified two crc gene products, a native Crc expressed in P. aeruginosa and a fusion protein expressed in E. coli. After placement of the crc gene behind a T7 promoter in pEB16 (creating pPZ456), the Crc protein became the major protein in soluble extracts of P. aeruginosa ADD1976 following induction of the T7 polymerase with IPTG (Fig. 7B) . This protein had a MW of approximately 30 kDa, which was identical to that identified as the crc gene product produced in P. aeruginosa from pPZ354 (reference 19 and above). The native protein was purified to approximately 60% purity, allowing for the identification of the following 10 amino acids from the N terminus: M-R-I-I-S-V-N-V-N-G. These 10 amino acids are in exact agreement with the nucleotide sequence presented in Fig. 3 . This purified protein was also recognized by antibodies prepared against the Crc fusion protein purified from E. coli (see below).
In E. coli M15, the crc gene product was produced from pPZ461 ( Fig. 7A) . Although the amount of Crc fusion protein produced in E. coli from this plasmid was increased over our original attempt (19) , it was less than that produced in P. aeruginosa (compare lane 4 with lane 10 in Fig. 7 ). The vector, pQE32, contains lac and T5 promoters and a ribosome binding site which is followed by a multiple cloning site which allows for in-frame cloning of a desired gene after six histidine codons. The fusion protein produced from this vector containing the crc gene was slightly larger than 30 kDa because of the added six histidines and the amino acids added at the N terminus to allow placement of the gene in frame with the histidine codons. Purification of the fusion protein over a Ni-NTA column resulted in a preparation which was greater than 95% pure. When the complete amino acid composition of this fu- b Cells were grown to late log phase in 2ϫ YT (yeast extract-tryptone) medium (21). They were concentrated 25ϫ by centrifugation and suspended in 50 mM potassium phosphate, pH 7.5. Samples of serial 10ϫ dilutions were plated on two identical 2ϫ YT plates. (Plates for strains carrying plasmids contained ampicillin.) One plate of each pair was incubated at 30ЊC, the other was incubated at 42ЊC. The numbers of colonies appearing on the plates were counted after 24 h. The relative plating efficiency is expressed as the ratio of the number of colonies growing at 42ЊC and 30ЊC. sion protein was determined, it was found to be in close agreement with the amino acid composition predicted from the nucleotide sequence (3).
We assayed both the purified native Crc protein and the fusion protein for both AP endonuclease and for exonuclease activities. Neither activity could be identified in either Crc protein, although we were able to detect AP endonuclease activity in purified human Ref-1 and both activities in purified E. coli ExoIII (3).
Detection of Crc in Pseudomonas species. Purified Crc fusion protein from E. coli was used to produce polyclonal antibody in a rabbit. Western blots were performed with this antiserum to look for antigenically similar proteins in crude soluble cell extracts from P. putida and P. fluorescens. Sera from nonimmune rabbits served as a control for specificity of the anti-Crc antibody. Figure 8 shows that crude extracts from the Pseudomonas strains each have a protein that is recognized only by anti-Crc antibody. These proteins from both strains have molecular weights similar to Crc. No protein which reacted specifically with anti-Crc antibody could be found in crude extracts from E. coli (3).
This same anti-Crc antiserum was used to look for the presence of Crc protein in crude extracts of crc mutants. Figure 9 shows that the knockout mutant, PAO8020, described above lacks a cross-reacting 30-kDa protein. Our second knockout, PAO8023, also lacks a cross-reacting 30-kDa protein (data not shown). Of two other mutants produced by chemical mutagenesis (47), PAO8005 contains a very small amount of the 30-kDa protein, while PAO8007 produces a 30-kDa protein which we assume to be nonfunctional. Both of these mutants are complemented by a 2-kb DNA fragment containing the crc ϩ gene and have a phenotype identical to PAO8020 (19) . PRP701 is a spontaneous crc mutant which also has a phenotype identical to PAO8005, PAO8007, and PAO8020 (48) . This mutant also presumably contains a defective Crc protein.
Crc is distinct from E. coli Cap. Recently, West et al. identified a gene from P. aeruginosa, vfr, which has 67% identity and 91% similarity to the E. coli crp gene and which complements the E. coli crp mutation (46) . To confirm that the Crc protein does not function in the same manner as the Cap protein in E. coli (also known as Crp), we attempted to complement the crc mutation with the vfr gene. The crc mutants, PAO8007 and PAO8020, were transformed with the vector pUCP18 and with the same vector carrying the vfr gene, pKF812. Each of these was grown in BSM-succinate plus mannitol or BSM-succinate plus lactamide, and the activities of mannitol dehydrogenase, glucose-6-phosphate dehydrogenase, and amidase were measured. In contrast to the complementation data shown in Fig. 4 and 5, all of these activities were identical and independent of the plasmid present (17) . The wild-type phenotype was not restored by the vfr ϩ plasmid as it was by the crc ϩ plasmids shown in Fig. 2 and 3 . Thus, the function of the Crc protein could not be replaced by the vfr gene product.
Since the phenotype of the crc mutants suggests the loss of a regulatory protein, we compared the sequence of Crc with that of other regulatory proteins. No significant homology was found to Cap from E. coli or to any other DNA-binding protein. The MOTIFS program was also used to look for helixloop-helix regions, common to DNA-binding proteins. No such regions were identified. No regions of the protein similar to any other sequence pattern in the Prosite database were found (at the level of zero mismatches). Nor were any matches found by using the PROFILESCAN program, which looks for structural and sequence motifs within proteins. For all searches, the entire amino acid sequence of the crc gene product was used as well as smaller portions of this sequence. VOL. 178, 1996 NUCLEOTIDE SEQUENCE AND EXPRESSION OF THE crc GENE 5633
DISCUSSION
We have isolated and sequenced 3.1 kb of P. aeruginosa chromosomal DNA which contains three genes, pyrE, rph, and crc. We have shown that a 922-bp fragment complements previously described crc mutants (19) . These mutants lack a gene essential for catabolite repression control. When the 922-bp sequence was interrupted with a tetracycline resistance gene and the defective crc gene was inserted into the chromosome of wild-type strain PAO1, a mutant with a phenotype identical to the original mutants was generated. Western analysis of crude extracts of this mutant showed that it lacked the 30-kDa protein.
The construction of this knockout should produce an almost full-length Crc protein (lacking eight amino acids), suggesting that the truncated protein is unstable in P. aeruginosa.
The 922-bp fragment contains an ORF encoding a protein of 259 amino acids with a relative molecular mass of approximately 28.5 kDa. Eighteen base pairs following the TGA stop codon is a strong factor-independent transcriptional terminator which is 26 bp in length. A potential ribosome binding site was identified upstream of the initiating ATG; however, this site was unique in that it contained only G residues. This lack of a typical E. coli ribosome binding site may provide a partial explanation for the low level of expression of the crc gene in E. coli, even from a strong promoter (19) . However, even when an appropriate ribosome binding site was provided in pPZ461, Crc represented a smaller percentage of the total protein in E. coli than in P. aeruginosa. Crc protein was purified from P. aeruginosa, and analysis of the first 10 amino acids are in exact agreement with those predicted from the DNA sequence.
A comparison of the predicted crc gene product to other known protein sequences led to the surprising finding that this protein shows homology to a group of DNA repair enzymes; however, all attempts to show that the Crc protein functions as an endonuclease proved negative. crc mutants show no increased sensitivity to DNA damaging agents, and the crc gene cannot complement E. coli xth or nfo mutants. The purified Crc proteins lack both endonuclease and exonuclease activity. Exonuclease activity is a feature of the bacterial enzymes belonging to this group. This suggests that, although the Crc protein may be related to this family of endonucleases, it does not have the same activity. Crc appears to be most closely related to the C. burnetii putative protein, with more similarity in the Cterminal region where Crc is less similar to the endonucleases (see Fig. 6 ). This suggests that these two proteins may have the same function. Perhaps, like the Ref-1 protein, the Crc protein has a regulatory function and a second function involved in DNA modification. Ref-1 stimulates the DNA-binding activity of the Fos and Jun transcription factors by an unknown mechanism and has endonuclease activity (45, 49) .
In order to identify a regulatory mechanism for the Crc protein, we have also tested both native and fusion Crc proteins for their ability to bind to small DNA fragments containing upstream regions of several Crc-regulated genes involved in carbohydrate catabolism. To date, gel shift assays indicate that the Crc protein has no specific DNA-binding activity. The possibility exists that this lack of binding is due to the absence of a cofactor required for binding of the Crc protein to the DNA. Therefore, experiments were carried out to look for DNA binding in the presence of various metabolites. Included in the binding mixtures were the following: acetyl coenzyme A, coenzyme A, AMP, ADP, ATP, cAMP, GTP, NAD-NADH, NADP-NADPH, and glutathione. Each was added to a separate Crc-DNA mixture, and binding was assayed by gel shift. In no case were we able to find any DNA-binding activity with native or fusion Crc protein (3) . Positive controls included a binding activity found in crude extracts of wild-type and crc mutant strains which does bind to these same regulatory regions of P. aeruginosa DNA (3) .
To demonstrate that the Crc protein functions in a different manner from E. coli Cap, we attempted to replace the defective Crc protein in crc mutants with the P. aeruginosa homolog of E. coli Cap. As expected, the vfr gene, which does complement E. coli crp mutants (46), did not complement crc mutants.
Thus, the Crc protein has been examined for modes of action suggested by its sequence and by its function. It has been exhaustively tested for endonuclease, exonuclease, and DNAbinding activities and was found to possess none of these. Moreover, the predicted amino acid sequence for the Crc protein showed no significant homology to any other protein(s) other than this family of eukaryotic and prokaryotic DNA repair enzymes, nor did it contain a structural motif common to any group of proteins in the Prosite bank. The actual mechanism of action of the Crc protein in catabolite repression control is likely to be quite different from that of any previously described prokaryotic regulatory protein. Perhaps, like Ref-1, instead of binding directly to DNA itself, it regulates gene expression by activating a DNA-binding protein. This could explain its ability to regulate multiple independent catabolic systems. Whatever its mechanism, it is likely that the same catabolite repression control system exists in the fluorescent pseudomonads, since we were able to identify proteins which were antigenically similar to Crc in P. putida and P. fluorescens but not in E. coli. The existence of a common mechanism of catabolite repression control in these closely related species is not surprising, since repression by organic acids has been observed in all three species (16, 42) .
